Resources from the same session
LBA13 - Tumour infiltrating lymphocytes (TILs), PD-L1 expression and their dynamics in the NeoTRIPaPDL1 trial
Presenter: Giampaolo Bianchini
Session: Mini Oral - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
162MO - Neoadjuvant chemotherapy and immunotherapy in Luminal B BC: Results of the phase II GIADA trial
Presenter: Maria Vittoria Dieci
Session: Mini Oral - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
163MO - Randomized phase II study of eribulin-based neoadjuvant chemotherapy for triple-negative primary breast cancer patients stratified by homologous recombination deficiency status (JBCRG-22)
Presenter: Hiroko Bando
Session: Mini Oral - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
164MO - Impaired Ki67 response towards neoadjuvant endocrine therapy in luminal breast cancer is associated with mutations conferring endocrine resistance: WSG-ADAPT HR+/HER2- translational results
Presenter: Isabel Grote
Session: Mini Oral - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
LBA14 - De-escalated neoadjuvant T-DM1 with or without endocrine therapy (ET) vs trastuzumab+ET in early HR+/HER2+ breast cancer (BC): ADAPT-TP survival results
Presenter: Nadia Harbeck
Session: Mini Oral - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
165MO - Patient (pt) preference for the pertuzumab-trastuzumab fixed-dose combination for subcutaneous use (PH FDC SC) in HER2-positive early breast cancer (EBC): Primary analysis of the open-label, randomised crossover PHranceSCa study
Presenter: Joyce O'Shaughnessy
Session: Mini Oral - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
166MO - A phase III trial to compare the efficacy, safety, pharmacokinetics and immunogenicity of HD201 to trastuzumab in HER2+ early breast cancer patients (TROIKA)
Presenter: Pivot Xavier
Session: Mini Oral - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
167MO - Longitudinal evaluation of serum assessed non-adherence to tamoxifen (TAM) among premenopausal patients (pts) in the prospective multicenter CANTO cohort
Presenter: Barbara Pistilli
Session: Mini Oral - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
168MO - GeparX: Denosumab (Dmab) as add-on to different regimen of nab-paclitaxel (nP)-anthracycline based neoadjuvant chemotherapy (NACT) in early breast cancer (BC): Subgroup analyses by RANK expression and HR status
Presenter: Theresa Link
Session: Mini Oral - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
169MO - Development and validation of a magnetic resonance imaging radiomics-based signature to predict axillary lymph node metastasis and disease-free survival in patients with breast cancer: A multicenter cohort study
Presenter: Herui Yao
Session: Mini Oral - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast